Literature DB >> 9414296

Cerebrovascular accidents in sickle cell disease: rates and risk factors.

K Ohene-Frempong1, S J Weiner, L A Sleeper, S T Miller, S Embury, J W Moohr, D L Wethers, C H Pegelow, F M Gill.   

Abstract

Cerebrovascular accident (CVA) is a major complication of sickle cell disease. The incidence and mortality of and risk factors for CVA in sickle cell disease patients in the United States have been reported only in small patient samples. The Cooperative Study of Sickle Cell Disease collected clinical data on 4,082 sickle cell disease patients enrolled from 1978 to 1988. Patients were followed for an average of 5.2 +/- 2.0 years. Age-specific prevalence and incidence rates of CVA in patients with the common genotypes of sickle cell disease were determined, and the effects of hematologic and clinical events on the risk of CVA were analyzed. The highest rates of prevalence of CVA (4.01%) and incidence (0.61 per 100 patient-years) were in sickle cell anemia (SS) patients, but CVA occurred in all common genotypes. The incidence of infarctive CVA was lowest in SS patients 20 to 29 years of age and higher in children and older patients. Conversely, the incidence of hemorrhagic stroke in SS patients was highest among patients aged 20 to 29 years. Across all ages the mortality rate was 26% in the 2 weeks after hemorrhagic stroke. No deaths occurred after infarctive stroke. Risk factors for infarctive stroke included prior transient ischemic attack, low steady-state hemoglobin concentration and rate of and recent episode of acute chest syndrome, and elevated systolic blood pressure. Hemorrhagic stroke was associated with low steady-state hemoglobin and high leukocyte count.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9414296

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  420 in total

1.  Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.

Authors:  Najibah A Galadanci; Shehu U Abdullahi; Musa A Tabari; Shehi Abubakar; Raymond Belonwu; Auwal Salihu; Kathleen Neville; Fenella Kirkham; Baba Inusa; Yu Shyr; Sharon Phillips; Adetola A Kassim; Lori C Jordan; Muktar H Aliyu; Brittany V Covert; Michael R DeBaun
Journal:  Pediatr Blood Cancer       Date:  2014-11-14       Impact factor: 3.167

Review 2.  The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.

Authors:  John J Strouse; Sophie Lanzkron; Victor Urrutia
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

3.  Stroke in Children.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

4.  Genetic predictors for stroke in children with sickle cell anemia.

Authors:  Jonathan M Flanagan; Denise M Frohlich; Thad A Howard; William H Schultz; Catherine Driscoll; Ramamoorthy Nagasubramanian; Nicole A Mortier; Amy C Kimble; Banu Aygun; Robert J Adams; Ronald W Helms; Russell E Ware
Journal:  Blood       Date:  2011-04-22       Impact factor: 22.113

Review 5.  Imaging in childhood arterial ischaemic stroke.

Authors:  Brynmor P Jones; Vijya Ganesan; Dawn E Saunders; W Kling Chong
Journal:  Neuroradiology       Date:  2010-05-06       Impact factor: 2.804

6.  Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease.

Authors:  Vicky Chaar; Julien Picot; Olivier Renaud; Pablo Bartolucci; Ruben Nzouakou; Dora Bachir; Frédéric Galactéros; Yves Colin; Caroline Le Van Kim; Wassim El Nemer
Journal:  Haematologica       Date:  2010-06-18       Impact factor: 9.941

Review 7.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

8.  Lower Transcranial Doppler Flow Velocities in Sickle Cell Anemia Patients on Hydroxyurea: Myth or Fact.

Authors:  Sawsan M Moeen; Ahmad F Thabet; Hosam A Hasan; Medhat A Saleh
Journal:  Indian J Hematol Blood Transfus       Date:  2017-04-08       Impact factor: 0.900

9.  Transient ischemic attack requiring hospitalization of children in the United States: kids' inpatient database 2003 to 2009.

Authors:  Malik M Adil; Adnan I Qureshi; Lauren A Beslow; Lori C Jordan
Journal:  Stroke       Date:  2014-02-12       Impact factor: 7.914

10.  Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea.

Authors:  Françoise Bernaudin; Cécile Arnaud; Annie Kamdem; Isabelle Hau; Françoise Lelong; Ralph Epaud; Corinne Pondarré; Serge Pissard
Journal:  Blood Adv       Date:  2018-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.